David Ricks, Eli Lilly CEO (Photographer: Jeenah Moon/Bloomberg via Getty Images)
Lilly says to ‘take some caution’ on other companies’ early-stage obesity data, calls out compounders
After posting a blowout quarter of financial results, Eli Lilly has almost made the obesity business look easy. But amid investors’ enthusiasm …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
